Development of innovative antimicrobials against pathogens resistant to antimicrobials[E8]

Aus der Bekanntmachung

Call: Cluster 1 - Health (Single stage - 2027/1). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: The scientific and clinical communities have a better understanding of and access to new and innovative products for the treatment of antimicrobial resistant bacteria and fungi, as well as for further clinical investigation. Candidate therapies are available to treat patients for antimicrobial resistant bacteria and fungi, increasing therapeutic options for clinical deployment in the fight against Antimicrobial Resistance (AMR). Scope: The rapid rise of AMR presents a formidable threat to public health, challenging our ability to treat infections that were once easily managed with standard antimicrobials. As pathogens continually adapt and develop resistance to existing drugs, the efficacy of these treatments diminishes, leading to more severe and prolonged illnesses, increased healthcare costs and productivity losses, and higher mortality rates. This escalating crisis underscores an urgent need for viable therapeutic alternatives required to reduce the burden of diseases caused by antibiotic resistance. Innovative solutions are crucial to maintaining effective disease management and safeguarding public health. Propos…[E3]

Die Angaben der Bekanntmachung werden so gezeigt, wie die Quelle sie veröffentlicht hat. Die Fakten und Anforderungen, die wir herausziehen, sind auf Englisch.

• Offen fürUniversities and research. Von SLETOR anhand der Wörter der Ausschreibung zugeordnet.
• BedingungEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]

• RisikoThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
• UnbekanntWe read the funder's listing, not the full guidance or application forms.

1. Für Angebote geöffnet · 29. Okt. 2026, 07:41 UTC

   The funder published the call with a future closing date.

   Geändert: status, notice type, published at (Quelldatensatz Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08))

2. Erstmals gesehen · 28. Okt. 2026, 21:22 UTC

   The funder announced the call. Applications have not opened yet.

   Quelldatensatz: Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08)

Jede Angabe auf dieser Seite stammt aus der Ausschreibung des Fördergebers. Jeder Eintrag zeigt den Datensatz und das Feld, aus dem er gelesen wurde.

1. E1

   The funder is European Commission.

   Aus Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), Feld /metadata/type/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

2. E2

   Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).

   “2027-02-17T00:00:00.000+0000”

   Aus Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), Feld /metadata/deadlineDate/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

3. E3

   The buyer describes the requirement in the notice.

   “Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed…”

   Aus Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), Feld /metadata/descriptionByte/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

4. E4

   EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.

   “EU call topic”

   Aus Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), Feld /metadata/type/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

5. E5

   This is an EU call for proposals.

   “31094502”

   Aus Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), Feld /metadata/status/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

6. E6

   Applications open on 29 Oct 2026.

   “2026-10-29T00:00:00.000+0000”

   Aus Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), Feld /metadata/startDate/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

7. E7

   The Funding & Tenders Portal gives the status as open for submission.

   Aus Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), Feld /metadata/status/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

8. E8

   The notice is titled "Development of innovative antimicrobials against pathogens resistant to antimicrobials".

   Aus Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), Feld /metadata/title/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

9. E9

   The EU contribution per grant is up to EUR 11,000,000 (from EUR 3,000,000).

   Aus Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), Feld /metadata/budgetOverview/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Datenlizenz: Creative Commons Attribution 4.0 (European Commission) ↗ (öffnet in neuem Tab). Persönliche Kontaktdaten aus Bekanntmachungen werden weder gespeichert noch angezeigt.